Specific properties of bat cells may thus be in part responsible for the ability of the animals to act as reservoirs for viruses in general and for novel reoviruses in particular. Their peculiar resistance to cell lysis also makes Tb1.Lu cells an attractive model to study the cellular and viral factors that determine the ability of reovirus to replicate and destroy infected cells.
Introduction
Mammalian reoviruses, as their name indicate, exhibit a large host-range and are able to infect most mammalian species and cell lines derived from these animals. Tropism for different cell types is also quite large, resulting in part from the binding to ubiquitous sialic acid and protein receptor JAM-A (reviewed by: Danthi et al., 2010) , as well as unidentified sugars and possibly protein receptors (Antar et al., 2009; Chappell et al., 2000) . However, proteolytic uncoating of the virus by lysosomal enzymes in the infected cell is often limiting (see for examples: Golden et al., 2002; Wetzel et al., 1997a,b) . Alternatively, the secretion of proteases in the external milieu could likely promote virus infection in some tissues including tumoral microenvironment (Alain et al., 2006 ; Amerongen et al., 1994; Bass et al., 1990; Bodkin et al., 1989 ).
In the last 20 years, there has been a renewed interest for these viruses due to their ability to preferentially infect transformed cells Coffey et al., 1998; Duncan et al., 1978; Hashiro et al., 1977; Marcato et al., 2007; Norman et al., 2004; Rudd and Lemay, 2005; Shmulevitz et al., 2010; Smakman et al., 2005; Strong and Lee, 1996; Strong et al., 1998;  reviewed by: Patrick et al., 2005) , leading to present clinical studies for their use as virotherapeutic "oncolytic" agents against cancer cells (reviewed among others by: Black et al., 2012; Harrington et al., 2010; Kelly et al., 2009 ). This preferential replication and cytolysis could result from the presence of a constitutively-active form of the Ras oncogene although other factors leading to cell immortalization and/or transformation are clearly involved, intensive research efforts are presently devoted to further clarify this aspect.
However, as for most viruses, studies of reovirus replication have been mostly performed in a few well-characterized cell types, mostly murine and human-derived. Furthermore, in the last few years, novel strains of reoviruses have been isolated from different animals species, especially wild bats, or in humans in contact with bats (Chua et al., 2007 (Chua et al., , 2008 (Chua et al., , 2011 Du et al., 2010; Kohl et al., 2012; Lelli et al., 2012; Pritchard et al., 2006; Thalmann et al., 2010; Wong et al., 2012) . These animals present a special interest since they are presently the object of intense studies as important reservoirs for many pathogenic and emerging viruses (reviewed in: Calisher et al., 2006; Hayman et al., 2012; Hughes et al., 2007; Wang, 2011; Wang et al., 2011; , 2007) . Some of the novel reoviruses are fusogenic and are thus quite different from the classically-studied non-fusogenic mammalian orthoreoviruses. However, other strains are nonfusogenic and are more similar to the previous classical isolates of mammalian reoviruses.
In the present study, the replicative ability of a classical non-fusogenic mammalian reovirus was examined in a bat lung epithelial cell line. Transient replication was observed with production of infectious virus without any apparent cytopathic effect. Virus production rapidly declined although a low level of virus production was maintained over at least two months of cell culture. Infected cells produced and released an antiviral soluble factor that can protect against an unrelated virus, even at times when virus production was reduced to very low levels. Prior uncoating of the virus did not enhance cytopathic effect, indicating that a blockage in entry is not responsible for the lack of cytopathic effect, as expected from high level of virus replication in the absence of prior uncoating. The Tb1.Lu cells exhibit a transformed phenotype, as demonstrated by their ability to form colonies in semisolid medium and further addition of a constitutively active Ras oncogene did not seem to affect virus infection or its effect on the host cells.
Materials and methods

Cells and viruses
L929 mouse fibroblasts and Vero cells (African green monkey kidney cells) were originally obtained from the American type culture collection (ATCC) and were grown in minimal Eagle medium (MEM) with 5% fetal bovine serum, with 1% penicillin and streptomycin (P/S) and 1% L-glutamine from commercial stock solutions (Wisent Bioproducts). Tb1.Lu mexican free-tailed bat (Tadarida brasiliensis) lung epithelial cells were a generous gift from the laboratory of Heinz Feldmann (Public Health Agency of Canada, Winnipeg, Canada) and were originally from ATCC (ATCC ® Number CCL-88 TM ). Tb1.Lu were grown in Dulbecco's modified Eagle medium (DMEM) with 10% fetal bovine serum, 1% P/S, 1% L-glutamine and 1% non-essential amino acids from commercial stock solutions (Wisent Bioproducts). Phoenix-ampho packaging cells (a fetal bovine serum and 1% P/S and 1% L-glutamine. Mouse NIH-3T3 fibroblasts were originally obtained from Yvan Robert Nabi (Life Sciences Institute of Cell and Developmental Biology, University of British Columbia) and were grown in Dulbecco's modified Eagle medium (DMEM) with 10% fetal bovine serum, 1% P/S, 1% L-glutamine, 1% non-essential amino acids and 1% vitamins from commercial stock solutions (Wisent Bioproducts) .
Clones of Tb1.Lu cells were obtained by by two methods. The method used for clones 1 to 3 is limiting dilution in 96-wells plates. Individual clones resulting from the growth of a single cell were then trypsinized and grown in 35mm plates and propagated before being infected. The other method used for clones 4 and 5 is trypsinisation of well-isolated colonies using small pieces of filter paper wetted with trypsin. Individual colonies were grown in 24-wells plates and propagated before being infected.
Wild-type reovirus used for most experiments was a laboratory stock derived from a pure plaque of reovirus serotype 3 strain Dearing (T3/Human/Ohio/Dearing/55; referred to as T3D);
in early experiments, the serotype 1 strain Lang (T1/Human/Ohio/Lang/1953; referred to as T1L) was also used. Both original inocula were obtained from the American Type Culture Collection (ATCC).
For the preparation of ISVPs, L929 cells were infected at a MOI of 2 PFU/cell in the absence of serum; following three cycles of freeze-thaw, chymotrypsin treatment (Sigma Type I-S from bovine pancreas) at 10μg/ml for 30 minutes at 37°C was done by direct addition of chymotrypsin to the virus-containing medium. The reaction was then stopped by addition of 2% heatinactivated fetal bovine serum.
Wild-type EMC virus (murine encephalomyocarditis virus) was a generous gift from Serge Dea (Institut Armand-Frappier, Laval, Qc, Canada) and was originally obtained from ATCC.
Antibodies
Hybridoma cell lines producing either anti-σ3 (4F2) or anti-μ1 (10F6) have been described (Virgin et al., 1991) and were a generous gift from Kevin Coombs (Winnipeg University). Hybridoma cells were grown in MEM for suspension culture with 10% fetal bovine serum, proline (20μg/ml) and β-mercaptoethanol (50μM) and antibodies were recovered as previously described (Brochu-Lafontaine and Lemay, 2012) . The FITC-conjugated goat antireovirus antibody was obtained from Accurate Chemical & Scientific Corporation (catalog # YV0031-10).
Determination of virus replication
At different times post-infection, infected cells in petri dishes were frozen directly with culture medium and submitted to three cycles of freeze-thaw before being titrated. Alternatively, medium was removed and separately frozen while fresh medium was added to the cells before being frozen and submitted to three cycles of freeze-thaw, as before.
Virus titers were determined by plaque assay on Vero cells in the presence of chymotrypsin (Sigma Type I-S from bovine pancreas) at 10μg/ml, as previously described (Brochu-Lafontaine and Lemay, 2012).
Immunoblotting
Infected cells were recovered by scraping in small volume of medium and centrifuged in an Eppendorf tube at 13 000 g for 5 minutes at 4°C. Cell pellets were resuspended in permeabilization buffer (Tris-HCl 10 mM pH 7.5, 1 mM EDTA, 150 mM NaCl, 1% Nonidet P-40) and left on ice for 5 minutes before centrifugation at maximum speed for 1minute in an Eppendorf centrifuge at 4°C. Proteins were analyzed by SDS-PAGE and immunoblotting.
Nitrocellulose membrane (Whatman Protran BA85) was blocked with 2% non-fat dry milk dissolved in TBS (Tris-HCl 10 mM pH 7.5, 150 mM NaCl) and sequentially incubated for one hour at room temperature with the anti-ơ3 and anti-μ1 monoclonal antibodies. Antibodies in tissue culture medium were diluted with an equal volume of TBS containing the blocking agent and directly used. The diluted antibody solution was recovered and kept at 4ºC with 1mM sodium azide to be used up to 10 times. 
Quantitation of reovirus-infected cells by FACS
Quantitation of reovirus-infected cells by FACS was done essentially as described by others 
Detection of secreted antiviral molecule.
L929 or Tb1.Lu cells were infected with wild-type reovirus type 3 Dearing at a multiplicity of infection of 5 and the supernatant was recovered 12 hours post-infection. This supernatant (5 ml)
was then placed in a 100mm-diameter petri dish and irradiated using the U.V. light of the tissue culture hood for one hour; in these conditions, infectious reovirus titer was reduced to less than the amount that can be detected in the assay used for detection of a secreted antiviral molecule. Phoenix-ampho packaging cells (Swift et al., 2001 ) were plated at a density of 4x10 6 cell per 100mm petri dish. The next day, cells were transfected using the calcium-phosphate precipitation method. PWZL-hygro control vector and PWZL-hygro Ras vector (Ferbeyre et al., 2000) were used at a concentration of 40µg/ml. The next morning, sodium butyrate was added at a final concentration of 10 mM and medium was changed in the afternoon in the transfected phoenix- 
Cell transformation assay: formation of colonies in semisolid medium
Cells were trypsinized and seeded in 6-wells plates at different cell concentrations (50 000, 10 000 and 2 000 cells per well) by mixing in complete culture medium containing 0.4% Noble agar (Difco) and overlaying over a preformed 0.8% Noble agar layer, also in complete medium. When medium has hardened, a layer of liquid medium was added on top and was subsequently changed each 3 days. After 14 days of cell growth, liquid medium was removed and replaced for 2 hours with medium without serum before being replaced again with 10% formaldehyde in PBS for cell fixation. Fixative was removed after one hour at room temperature and cell colonies were stained by adding 0.01% crystal violet in PBS for one hour at room temperature, followed by extensive washing in PBS .
Results
Absence of reovirus-induced cytopathic effect in reovirus-infected Tb1.Lu cells
Bat cells are poorly studied as in vitro models of reovirus infection and replication. Therefore, it was first sought to know if reovirus could replicate efficiently in an epithelial lung cell line In order to determine whether the absence of cell lysis could be due to an overall resistance of 
Tb1.Lu cells support reovirus replication despite absence of cytopathic effect.
To determine if reovirus actually infects and replicates in Tb1.Lu cells, cultures of infected cells were recovered at different times post-infection and submitted to three cycles of freezethaw before virus titration, as described in Materials and methods. Virus replication was detected from 48 hours, total virus produced stabilizes between 3 and 6 days and total amount remained constant thereafter, suggesting transient replication despite absence of cell lysis (data not shown).
In order to further examine virus production, infected cells and their supernatants were separately recovered at different times post-infection before freeze-thaw and virus titration. Since there was no cell passage nor change of medium, this experiment thus examine the accumulation of infectious virus over time. Again, viral replication was clearly observed and virus release in the supernatant was observed despite absence of cell lysis. A peak of infectious virus was observed around 48-72 hours post-infection and then decreased gradually inside the cells and remained constant in the supernatant. Total infectious virus production and final viral titers were similar in L929 cells (after 24 hours) and Tb1.Lu cells at the 48-72 hours peak (data not shown). This confirms that virus replication actually occurs and decreases after peak replication and that the virus present in the supernatant was produced in the first few days (Figure 2A ).
In parallel of the last experiment, cell lysates from infected cells with either serotype 1 (T1L) and serotype 3 (T3D) virus was recovered for western blot analysis ( Figure 2B ). Viral proteins were easily observed in parallel with the increase in virus titer. Although viral proteins in T1L-infected cells were detected at earlier times, a similar decrease at later times was observed with both viruses and no significant cell death was observed in either cases; this is also consistent with similar amounts of total proteins, as detected by Coomassie blue staining, for either infected or control mock-infected cells. Increasing the multiplicity of infection to 50 did not seem to enhance cytopathic effect in any significant way. Infected cells at either MOI could be kept for up to 50 days without any apparent effect on cell survival (data not shown).
Infection of individual Tb1.Lu cells in the cell culture
Although there was no visible cell death in all previous experiments, the possibility remains that only a small fraction of the cells transiently produce large amount of viruses and are 
Limited uncoating is not mainly responsible for the phenotype of Tb1.Lu cells to reovirus.
As mentioned in the introduction, the ability to uncoat the reovirus virions to generate infectious subviral particles (ISVPs) is often a limiting factor for viral replication. (Fig. 4A) . Kinetics of infectious virus produced was also examined and confirmed faster replication of ISVPs, compared to virions, with similar virus titers at later times (Fig. 4B) . Faster kinetics of infection by ISVPs compared to virions suggest that inefficient virus uncoating limits reovirus infection in Tb1 cells but only to a certain extent;
bypassing the uncoating step with ISVPs is not sufficient to increase cell lysis nor final viral production. Cells initially infected by ISVPs, as well as those initially infected by virions, could be kept for a long time without apparent cytopathic effect.
Secretion of an antiviral molecule by Tb1.Lu cells early after reovirus infection.
One possible explanation for Tb1.Lu cells resistance to reovirus-induced cytopathic effect, and rapid decrease in virus produced, could be the presence of a strong antiviral mechanism in these cells; one likely possibility is the secretion of an antiviral factor, such as interferon. Since reovirus serotype 1 Lang is known to be more resistant to this cellular defense mechanism both at the level of induction and sensitivity (Jacobs and Ferguson, 1991; Zurney et al., 2009 ), this will be consistent with the previous observation that this virus isolate was slightly more efficient in infecting Tb1.Lu cells than was serotype 3 Dearing.
The ability of Tb1.Lu cells to secrete an antiviral molecule was thus examined by recovering supernatants of reovirus-infected cells at 12 hours post-infection and testing its antiviral ability on an unrelated virus, namely the murine encephalomyocarditis virus, as an indicator virus that is highly sensitive to interferon. Interestingly, while supernatants of reovirus-infected L929 cells only reduced apparent EMC titer by approximately 4-fold under these conditions, the supernatant from Tb1.Lu cells exhibited a strong antiviral activity, being able to reduce apparent EMC titer by more than a thousandfold (Fig. 5) . This suggests the induction and secretion of a strong antiviral factor, most likely interferon, early during infection of these cells, that may be responsible for the rapid decline in synthesis of viral proteins and infectious virus production, possibly also explaining the lack of concomitant cytopathic effect. 
Introduction of a constitutively active form of Ras in Tb1.Lu cells does not affect reovirus replication and virus-induced cytopathic effects.
As mentioned in the introduction, expression of a constitutively-active form of Ras, The cells were first examined for their ability to behave as transformed cells using the soft agar colony formation assay (Fig. 6) . only a small increase, less than twofold upon quantitation, in Tb1.Lu-Ras cells (Fig. 7) ; furthermore, both cell lines resisted reovirus-induced cytopathic effect and could be passaged for up to two months without any apparent effect on cell survival. This indicates that oncogenic Ras does not have a significant effect on reovirus infectivity, or cell-induced cytopathic effect, in this cell type and lack of activation of Ras signalling pathways is unlikely to explain the resistance of these cells.
Long-term infection of Tb1.Lu cells.
In order to clarify if the virus is eventually cleared from infected cells, these were kept for up to a month in two different conditions. In one case, medium was changed twice a week but cells were never passaged; it was found that these cells can actually remain viable under these conditions and can then be passaged with a minimum loss of viability. Another culture of infected cells was rather trypsinized twice a week at the same cell concentration each time;
again, there was no apparent change in growth properties of these cells and the number of cells remained essentially constant at all time.
Infectious virus production was then measured in the supernatant by virus titration, as well as remaining infectious virus present intracellularly. The amount of infectious virus remained high in the cell culture when cells were not passaged (data not shown), despite the fact that there was no cell killing nor apparent cytopathic effect. In contrast, virus production was reduced by at least a thousandfold compared to acutely-infected cells when cells were regularly passaged, suggesting the need for constant reinfection to maintain the virus in dividing cells (Fig. 8 , reduced in the passaged culture, was sufficient to prevent any further reinfection, probably by maintaining the presence of the soluble antiviral factor (Fig.8) .
Virus released from late-infected cells was also recovered and used to infect either L929 or fresh Tb1.Lu cells; while L929 cells were readily killed by the infection, Tb1.Lu cells resisted to this virus, as well as to the original wild-type virus (data not shown). There is thus no evidence that the "adapted" virus has evolved to acquire more cytopathogenicity toward the Tb1.Lu cells.
Discussion
In the last few years, different reoviruses have been found in various species of bats. In this project, in vitro replication of a classical mammalian reovirus was examined in bat cells. These cells differ from most in vitro cellular models of reovirus infection since no cytopathic effect was observed despite viral replication and release in the external medium. The mechanism of virus release from these cells remains to be explored. In the closely related avian reovirus, as well as in rotavirus, another member of the Reoviridae family, it has been observed that autophagy contributes to virus replication and/or propagation (Meng et al., 2012; Crawford et al., 2012) . It cannot be excluded that autophagy could be involved in nonlytic virus release in Tb1.Lu cells, as well as during viral persistence in these and other cell types. Alternatively, recent data indicate a recycling mechanism from endocytic compartments to the cell surface (Mainou and Dermody, 2012 ) that may be also used in the case of nonlytic virus release.
Bat Tb1.Lu cells were previously shown to support persistent infection with Ebola virus (Strong et al., 2008) . However, the absence of cell death and establishment of persistence following virus infection is not a general property of Tb1.Lu cells since they were readily infected and killed by encephalomyocarditis virus.
Among the different cell lines that have been examined over the years, and that can actually support a productive reovirus infection, some of these nevertheless exhibit partial resistance to viral induced cell death at early times post-infection while eventually becoming persistently infected (see for examples: Alain et al., 2006; Danis et al., 1993; Kim et al., 2007; Taber et al., 1976; Verdin et al., 1986) . However, detailed data of the kinetics and long-term cultures of (Montgomery et al., 1991) , although the cells still exhibited limited cell growth once infected. Furthermore, in our laboratory, MDCK cells were found to be killed upon reovirus infection (Danis and Lemay, 1993; Bisaillon et al., 1999) . Recent data indicate that the fate of infected MDCK cells depends on postentry events that are regulated by a specific viral protein varying between type 1 Lang and type 3 Dearing virus strains (Ooms et al., 2010) , differences between virus stocks could thus possibly explain these conflicting results between laboratories. In the present manuscript, there was no striking difference between the Lang and Dearing strain for the replication in Tb1.Lu cells and most of the present work only used the latter strain. However, it will certainly be interesting to examine different virus mutants for their ability to replicate and eventually kill infected cells.
In most cell lines, long-term infection results in viral persistent infection with resulting viruscell coevolution (Dermody et al., 1993; Wetzel et al., 1997b; reviewed by: Dermody, 1998) . In the few cases examined to date, amino acids substitutions in the σ3 protein were consistently observed in the viruses recovered from persistently-infected cells (Wetzel et al., 1997b; Kim et al., 2010) . In the viruses from persistently-infected L929 cells, these substitutions were shown to increase viral uncoating by small amounts of lysosomal proteases, resulting in an ability to infect cells that possess a limiting amount of these enzymes, as observed in the persistently-infected cells (reviewed by: Dermody, 1998). With viruses obtained from "persistently-infected" Tb1.Lu cells, the lack of cytopathic effect of these viruses on Tb1.Lu cells, and the limited impact of prior uncoating of the original virus, suggests that it is unlikely that the virus has actually evolved to acquire a better efficiency of uncoating. Tb1.Lu cells infected with either virions or ISVPs were recovered at different times postinfection, subjected to three cycles of freeze-thaw and total infectious virus titered, as described in Materials and methods. 
